Increased CD16 and CD57 levels and CD56+ lymphocyte numbers are reported in peripheral blood (PB) and BM samples of untreated patients with MM, respectively, compared with those of matched healthy volunteers. Here, FCGR3A is linked to Miyoshi myopathy.